Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TALPHERA, INC. | Director | Common Stock | 4.59K | $5.05K | $1.10 | Jun 24, 2024 | Direct |
TALPHERA, INC. | Director | Stock Option (Right to Buy) | 13K | Jun 24, 2024 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | Dec 28, 2021 | Direct | |
Dicerna Pharmaceuticals Inc | Director | Director Stock Option (Right to Buy) | 0 | Dec 28, 2021 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | Dec 28, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TLPH | TALPHERA, INC. | Jun 24, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
ACRX | ACELRX PHARMACEUTICALS INC | Oct 10, 2023 | 2 | $0 | 4 | Dec 13, 2023 | Director |
ACRX | ACELRX PHARMACEUTICALS INC | Jul 15, 2022 | 2 | $0 | 4 | Jul 15, 2022 | Director |
DRNA | Dicerna Pharmaceuticals Inc | Dec 28, 2021 | 11 | -$618K | 4 | Dec 29, 2021 | Director |
ACRX | ACELRX PHARMACEUTICALS INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |
DRNA | Dicerna Pharmaceuticals Inc | Jun 3, 2021 | 4 | $0 | 4 | Jun 7, 2021 | Director |